http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110742900-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-19 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-05 |
| filingDate | 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110742900-B |
| titleOfInvention | Chlorella extracellular polysaccharide compound with immunoregulation activity and preparation method and application thereof |
| abstract | The invention discloses a chlorella extracellular polysaccharide compound with immunoregulation activity and a preparation method and application thereof. The extracellular polysaccharide complex is extracted from Chlorella protothecoides CS-41 fermentation liquor, is obtained by separation and purification procedures such as anion exchange chromatography, gel exclusion chromatography and the like after protein is removed by filtering, centrifuging, concentrating, alcohol precipitating and Sevage method, and is white powder, the average relative molecular weight of the polysaccharide complex is 170kDa, and the polysaccharide complex consists of lipid and polysaccharide, wherein the lipid contains palmitic acid and stearic acid, and the polysaccharide consists of rhamnose, xylose, mannose and glucose. The extracellular polysaccharide complex disclosed by the invention is clear in composition, has an immunoregulation effect, can obviously reduce the levels of inflammatory factors (ROS, iNOS, IL-6 and TNF-alpha), and has a wide application prospect in clinical and related medical care fields. |
| priorityDate | 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.